STOK · Stoke Therapeutics, Inc. · Documents
$26.87
+2.05 (+8.24%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.60B
Shares
64.53M
Volume · Oct 20
560.45K
Avg daily vol (3M)
874.21K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2022-03-10 | 2021-12-31 | |
| 8-K | — | 2022-02-17 | 2022-02-11 | |
| 8-K | — | 2022-01-10 | 2022-01-09 | |
| 8-K | — | 2021-12-17 | 2021-12-14 | |
| 8-K | — | 2021-12-03 | — | |
| 8-K | — | 2021-11-08 | — | |
| 10-Q | — | 2021-11-08 | 2021-09-30 | |
| 8-K | — | 2021-09-21 | — | |
| 8-K | — | 2021-09-09 | 2021-09-08 | |
| 10-Q | — | 2021-08-10 | 2021-06-30 | |
| 8-K | — | 2021-08-10 | — | |
| 8-K | — | 2021-06-09 | 2021-06-08 | |
| 10-Q/A | — | 2021-05-14 | 2021-03-31 | |
| 10-Q | — | 2021-05-10 | 2021-03-31 | |
| 8-K | — | 2021-05-10 | — | |
| DEF 14A | — | 2021-04-26 | 2021-06-08 | |
| DEFA14A | — | 2021-04-26 | — | |
| 8-K | — | 2021-03-09 | — | |
| 10-K | — | 2021-03-09 | 2020-12-31 | |
| 8-K | — | 2021-02-05 | — | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2020-11-20 | 2020-11-19 | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-11-12 | — | |
| 8-K | — | 2020-10-07 | — | |
| 8-K | — | 2020-08-21 | 2020-08-17 | |
| 8-K | — | 2020-08-17 | 2020-08-13 | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-08-10 | — | |
| S-3 | — | 2020-07-10 | — | |
| 8-K | — | 2020-07-09 | — | |
| 8-K | — | 2020-06-04 | 2020-06-03 | |
| 10-Q | — | 2020-05-15 | 2020-03-31 | |
| 8-K | — | 2020-05-15 | — | |
| 8-K | — | 2020-05-12 | — | |
| DEF 14A | — | 2020-04-21 | 2020-06-03 | |
| DEFA14A | — | 2020-04-21 | — | |
| 8-K | — | 2020-04-15 | 2020-04-14 | |
| 8-K | — | 2020-03-23 | — | |
| 10-K | — | 2020-03-23 | 2019-12-31 | |
| 8-K | — | 2020-01-13 | — |
Showing 101–141 of 141 filings
Key facts
CIK
1623526
CUSIP
86150R107
13F (30d)
10 filings
10 filers
Visit website
Investor relations